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Abstract
Background: B-RAF kinase plays an important role both in tumour induction and maintenance in
several cancers and it is an attractive new drug target. However, the structural basis of the B-RAF
activation is still not well understood.
Results: In this study we suggest a novel molecular basis of B-RAF activation based on molecular
dynamics (MD) simulations of B-RAFWT and the B-RAFV600E, B-RAFK601E and B-RAFD594V mutants.
A strong hydrogen bond network was identified in B-RAFWT in which the interactions between
Lys601 and the well known catalytic residues Lys483, Glu501 and Asp594 play an important role.
It was found that several mutations, which directly or indirectly destabilized the interactions
between these residues within this network, contributed to the changes in B-RAF activity.
Conclusion:  Our results showed that the above mechanisms lead to the disruption of the
electrostatic interactions between the A-loop and the αC-helix in the activating mutants, which
presumably contribute to the flipping of the activation segment to an active form. Conversely, in
the B-RAFD594V mutant that has impaired kinase activity, and in B-RAFWT these interactions were
strong and stabilized the kinase inactive form.
Background
The identification and characterisation of functional tar-
gets that play an essential role in tumour growth and sur-
vival, is of imperative importance to the success of novel
cancer therapies. B-RAF, a member of the RAF kinase fam-
ily, is an important new therapeutic target for a group of
human cancers, as it constitutes activation of the RAF-
MEK-ERK pathway common to numerous cancers [1].
Recently, large-scale genomic screens have detected muta-
tions in B-RAF in about 70% of malignant melanomas
and at a lower frequency in colorectal and ovarian cancers
[2]. Other cancer types have been found to harbour B-RAF
mutations. Over 40 mutations have already been identi-
fied [3,4]. Some of these mutants, B-RAFE586K, B-RAFV600E,
B-RAFV600D, B-RAFV600K, B-RAFV600R and B-RAFK601E, have
a much higher kinase activity in vitro than the basal wild
type B-RAF (B-RAFWT)  activity and were classified as
strongly activating [4]. Mutations at nine amino acid posi-
tions that are less activating, but exhibit activity above the
basal, belong to an intermediate activity group [4].
Although most B-RAF mutants display elevated kinase
activity compared to the B-RAFWT, four cancer-derived
mutants have reduced kinase activity: B-RAFG466E, B-
RAFG466V, B-RAFG596R and B-RAFD594V [3,4].
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Most of the mutations of B-RAF are clustered in two differ-
ent regions within the binding pocket, one is the glycine-
rich P-loop (P-loop) of the N lobe and the other one is the
activation segment (named A-loop here). A substitution
of Val by Glu at residue 600 in the A-loop, adjacent to the
conserved DFG motif, accounts for 90% of B-RAF muta-
tions in human cancers. B-RAFV600E has a 500-fold higher
kinase activity, relative to the basal activity of B-RAFWT,
providing cancer cells with both proliferation and survival
signals and allowing them to grow as tumours in model
systems [4].
The activation of B-RAFWT requires phosphorylation of the
Thr599 and/or Ser602 residues within the A-loop [5]. It
has been suggested that the V600 mutations mimic the
phosphorylation step [2], and has also been stated that
most of the B-RAF mutants can activate MEK directly and
thereby stimulate ERK [3,4]. However, the mutated and
activated B-RAFV600E binds to a Hsp90-cdc37 complex,
which is required for its stability and function [6]. Three
of the impaired kinase activity mutations (B-RAFG466E, B-
RAFG466V and B-RAFG596R) are capable of inducing ERK
phosphorylation through heterodimerization with C-
RAF. The fourth mutant (B-RAFD594V) acts like a kinase-
dead mutant and cannot bind to C-RAF. Its role in tumor-
igenesis remains to be elucidated [3]. It is not surprising
that B-RAFD594V  is a loss-of-function mutant, because
Asp594 is a key catalytic residue for many kinases [7]. The
impact of the D594V mutation on the B-RAF conforma-
tion, and in particular on the coordination and interac-
tion with ATP binding residues such as Lys483, Glu501
and Asp594 is yet unclear.
Crystal structures of the inactive B-RAFWT and B-RAFV600E
kinase binding domains in a complex with the BAY-
439006 (Sorafenib) inhibitor have been solved [4]. It has
been suggested that the molecular interactions between
the P-loop and the A-loop in B-RAFWT stabilize the inac-
tive form, and that the substrate recognition leads to con-
formational changes that set the catalytic cleft free and
allows the enzyme to achieve a full active state [4,8]. In
particular, interactions between Phe468 in the P-loop and
Val600 in the A-loop were identified and based on this
observation it has been predicted that the mutations of
Val600 to a larger and more charged residues will lead to
conformational change within the A-loop, flipping it to
the active position. Such structural model could also
explain the strong increase in the kinase activity caused by
the G469A mutation in the P-loop and intermediate
increase in activity for a group of other P-loop mutants.
However, the molecular basis of the strong B-RAF activa-
tion by the K601E mutation remains unclear, and it is also
difficult to explain the strong kinase activity by the B-
RAFE586K mutant, and the intermediate activation by the
N581S, F595L, L597V, L597R and T599I mutations
within in frame of the present literature model, because
none of these residues are in a close contact with the P-
loop. Moreover, the position of Phe468 in a newly
obtained crystal structures of the inactive B-RAFWT [9] dif-
fers significantly from the corresponding position in pre-
viously solved crystal structures. The new data showed
that in a presence of a ligand smaller than Sorafenib or
with no inhibitor present in the binding site, Phe468 has
an orientation toward the αC-helix and is unlikely to
interact with Val600. The results from MD simulations of
B-RAFWT, B-RAFV600E  and B-RAFV599Ins showed that the
electrostatic interactions between the A-loop, the P-loop
and the αC-helix are an important factor for the confor-
mational stability of the activation segment in B-RAFWT
and in the mutations causing disruption of these interac-
tions, but the particular contribution of the αC-helix to
these processes was not specified [10]. Further, the molec-
ular bases for the ligand inhibition, selectivity and confor-
mation stability in inactive B-RAFWT and B-RAFV600E has
been studied, indicating that the αC-helix – A-loop inter-
actions play a crucial role in B-RAF activation. In this
study the Lys601 residue in the A-loop and the Glu501
residue in αC-helix were identified to provide the strong-
est electrostatic component to the overall interactions
within the protein-ligand complex [11].
Recently, crystal structures of the active form of B-RAF (B-
RAF-A), i.e. the kinase with the A-loop moved to its active
position, were obtained [9,12]. The conformational
change of the A-loop is a major structural feature that
occurs during the kinase activation [3,4,12]. Due to its
conformational flexibility, some of the residues in the A-
loop were not resolved in all available crystal structures of
the active as well as inactive B-RAF forms.
In the present paper we suggest a molecular basis for sev-
eral of the experimentally observed B-RAF kinase activity
deviations induced by the mutations. We study the direct
and indirect changes caused by the mutants on a strong
hydrogen bond network identified in the B-RAF wild type,
and put forward a hypothesis on how the observed struc-
tural changes contribute to the experimentally measured
kinase activity deviations.
Methods
Preparation of protein structures
Firstly, the structures of B-RAFWT and B-RAFV600E were pre-
pared as described in a previous publication [11]. By
retrieving the atomic coordinates of available crystal struc-
tures for B-RAFWT and B-RAFV600E from the protein data
bank [13] (pdb codes: 1uwh and 1uwj) and removing the
inhibitor Sorafenib from the protein while keeping the
crystal waters, initial structures for these B-RAF forms were
generated. The loop building routine of Modeller [14] was
used to create models for the regions not solved into theBMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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crystal structures, which are residues 601–612 for B-
RAFWT and 603–614 for B-RAFV600E, as describe previously
[11].
The mutants B-RAFK601E and B-RAFD594V were constructed
using the crystal structure of B-RAFWT in each case by sub-
stituting the corresponding residue with the mutation.
Then the A-loop region was modelled and refined using
the same procedure as was used for the two other B-RAF
forms.
Molecular dynamics simulations
For each of the B-RAF kinases studied, a 15 ns MD simu-
lation was done. The structures of the different B-RAF
forms were prepared with the Amber 9 software [15] and
all the MD simulations were done with NAMD v.2.6 [16].
All simulations were carried out at neutral pH. The Lys
and Arg residues are positively charged, and the Asp and
Glu residues are negatively charged. The default His pro-
tonated state in Amber 9 was adopted. Each of the simu-
lated systems was placed in the centre of a cubic
simulation box filled with water molecules. The SPC/E
water model [17] was used for the waters and the buffer-
ing distance was set to 10 Å. Counter ions were added to
maintain the electroneutrality of the complexes. The
Amber ff03 force field was employed for the simulations
[18]. All systems were energy minimized in two steps.
Firstly only the water molecules and ions were minimized
for 2000 steps while keeping the protein structure fixed.
Secondly, a 8000 step minimization with the conjugate
gradient method to convergence criterion of 0.5 kcal mol-
1 Å-1 was performed on the whole system (waters, ions and
protein). The simulated systems (the different B-RAF
forms) were then gradually heated from 0 to 300 K for 50
ps (NTV), equilibrated for 200 ps, and finally production
runs of 15 ns (NTP) were performed. Langevin dynamics
was used to keep the temperature constant throughout the
simulation time, setting the Langevin damping coefficient
to 5 ps-1. The hybrid Nosé-Hoover Langevin piston
method with a decay period of 200 fs and a damping
time-scale of 50 fs was used to keep the pressure constant
at 1 atm. A non-bonded cut-off of 12.0 Å and the switch-
ing distances were imposed to10 Å and 14 Å respectively.
The SHAKE algorithm was used for all bonds involving
hydrogen atoms [19]. A 2 fs integration time step was
used, and the particle-mesh Ewald (PME) method [20]
was applied to model the long-range electrostatic interac-
tions. Data were collected every 500 steps, i.e., every 1 ps.
The average distances and corresponding standard devia-
tions (SD) were calculated with the VEGA software [21].
The interactions energies between selected protein sub-
structures and residues were calculated with NAMD. Cal-
culation of the root-mean-square deviations (RMSD), the
root-mean-square fluctuations (RMSF) and the corre-
sponding SD values and visualisations of the protein
structures were done with the VMD package and its Tcl
routine [22].
Results and discussions
Overall molecular dynamics analysis
In order to establish a link between the structural changes
that occur within the binding pocket of B-RAF and the
experimentally observed activity deviations, a detailed
analysis of the MD simulation results was performed.
Thus structural analysis of the B-RAF wild type and the
three mutants is used as bases for a hypothesis on the
effect the various mutation inflict on the B-RAF activity on
ERK protein.
Figures 1A and 1B present the RMSD of the backbone pro-
teins atoms during the 15 ns of simulation and the RMSF
of the Cα atom in each residue, respectively. The wild type
protein reached a reasonable equilibration after 1.5 ns
whereas for the mutants it took 3.5 ns until equilibrium
was reached. A good RMSD convergence for all the three
mutants was reached after 9 ns. These data are consistent
with recently obtained MD results for the structurally sim-
ilar Abl kinase [23], suggesting that at least a few nanosec-
onds of equilibration are required to study these systems.
It was observed that both the active mutants, B-RAFV600E
and B-RAFK601E, have a similar evolution of the RMSD
curve, whereas the curve for the inactive mutant, B-
RAFD594V, evolves differently. However, the observed sim-
ilarity between the two curves could be an artefact of the
A-loop missing portion model. Each form of the B-RAF
reaches stable equilibrium conformation, which are used
for the analysis presented in the paper. The analysis of the
RMSF graph showed that there were four major flexible
protein elements present in all the studied proteins. These
are the loop that links the β3 strands and the αC helix
(named C-loop here), the loop between the A-loop and
the αF-helix (named F-loop here), the A-loop and the αG-
helix (see Figures 1B and 2A). The fluctuations of the res-
idues were higher in magnitude in the mutants than for
the wild type. The A-loop residues flexibility was high and
varied in the individual kinases, but was most strongly
expressed in the V600E mutant.
In order to study the contribution of the protein structural
elements to the A-loop kinase conformational stability,
the van der Waals and electrostatic interactions between
the A-loop and the surrounding protein sub-structures
were calculated. The interactions between the A-loop (res-
idues 593–623) and the closest five neighbouring sub-
structures, the P-loop (residues 462–471), the αC-helix
(residues 492–506), the β6 strand (residues 571–578),
the F-loop (residues 625–634) and the αG-helix (residues
660–672), were analysed, see Tables 1A and 1B. An inves-
tigation of the energy contributions of the individual pro-
tein residues to these processes was performed too. TheBMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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Overall molecular dynamics analysis Figure 1
Overall molecular dynamics analysis. A) The RMSD of the proteins backbone atoms (C, Cα and N atoms) for the differ-
ent kinase forms, B-RAFWT, B-RAFV600E, B-RAFK601E and B-RAFD594V. B) The RMSF of the proteins Cα atom for each residue of 
the different kinase forms, B-RAFWT, B-RAFV600E, B-RAFK601E and B-RAFD594V.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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B-RAFWT Figure 2
B-RAFWT. A) The conformation of B-RAFWT after 15 ns of simulation time. The different structural elements in the protein 
are coloured according to the structure method in VMD and the names of the sub-structures are shown. The A-loop contains 
30 residues and is in the space between the P-loop, the αC-helix, the β6-strand, the F-loop and the αG-helix (see text for 
details). B) A close look at the conformation of the major catalytic residues and the identified hydrogen bond network in the 
unbounded B-RAFWT after 15 ns of simulation time (The position of Gly596 is shown in Figure 7). The dotted lines and the 
adjacent numerical values represent the H-bonds and their distances.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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data were extracted for the period 10–15 ns of simulation
time when a good convergence was reached for all the
four B-RAF forms. A similar approach was recently used
for B-RAFWT, B-RAFV600E and B-RAFV600Ins, but the particu-
lar interactions between the A-loop, the αC-helix and the
P-loop, as well as the contribution of the other sub-struc-
tures, were not specified [10].
Furthermore, the evolution of the electrostatic interaction
energy between key residues throughout the whole simu-
lation time was plotted, and used to examine the struc-
tural changes occurring within the binding pocket of B-
RAF during the simulation. As part of the A-loop was not
resolved in the available crystal structures, the contribu-
tion of the modelled A-loop portion to the overall struc-
tural changes of the different B-RAF mutations had to be
evaluated. Thus the A-loop region of the mutants was fur-
ther divided into two portions, A-loop1 (residues 593–
602 resolved in the crystal structure) and A-loop2 (resi-
dues 603–614 not solved in the crystal structure), and
interaction energies between these two portions and other
keys residues were studied separately.
This analysis was focused on structural changes occurring
within the ATP binding site. The electrostatic and van der
Waals interaction energies between key residues and pro-
Table 1: An overview of the calculated interaction energies (kcal/mol) between key sub-structures and residues in A) B-RAFWT and B-
RAFV600E and in B) B-RAFK601E and B-RAFD594V.
A) B-RAFWT B-RAFV600E
Substructure vdW El Total vdW El Total
A-loopa -100.9 ± 6.9 -200.1 ± 18.6 -301.0 ± 16.5 -99.1 ± 5.6 -153.6 ± 24.4 -252.7 ± 24.5
A-loop-αC-helixb -20.2 ± 1.9 -31.4 ± 5.9 -51.6 ± 5.4 -27.0 ± 3.2 -5.8 ± 10.6 -32.8 ± 9.9
A-loop-P-loopc -12.7 ± 2.2 -18.2 ± 5.5 -30.9 ± 5.1 -22.6 ± 2.0 -11.9 ± 2.8 -34.5 ± 3.2
A-loop-β6-strandd -12.4 ± 2.7 -31.6 ± 8.6 -44.0 ± 8.4 -14.2 ± 2.1 -44.5 ± 9.3 -58.7 ± 8.9
A-loop-F-loope -18.5 ± 1.8 -3.4 ± 4.4 -21.9 ± 4.1 -15.3 ± 2.7 -20.3 ± 23.5 -35.6 ± 23.4
A-loop-αG-helixf -3.6 ± 1.3 -33.6 ± 7.4 -37.2 ± 7.3 -0.7 ± 0.3 -6.4 ± 2.5 -7.1 ± 2.6
Lys601g -14.9 ± 2.3 -150.3 ± 15.1 -165.2 ± 14.8 -15.8 ± 2.3 -137.7 ± 12.7 -153.5 ± 12.1
Lys601-αC-helixh -0.7 ± 1.5 -73.3 ± 9.9 -74.0 ± 9.2 -3.2 ± 0.5 -22.8 ± 3.1 -26.0 ± 3.1
Lys483-Asp594i -0.1 ± 0.9 -69.0 ± 9.5 -69.1 ± 9.0 -0.3 ± 0.1 -39.4 ± 4.4 -39.7 ± 4.5
Lys601-Asp594j -0.2 ± 0.6 -58.2 ± 4.2 -58.4 ± 4.0 -1.5 ± 3.9 -61.5 ± 4.5 -63.0 ± 3.4
(K601-D594)-k
(E501-K483)
-0.9 ± 1.7 -70.8 ± 7.5 -71.7 ± 6.7 -4.0 ± 0.5 0.2 ± 3.5 -3.8 ± 3.5
(K601-D594)-l
(D576-N581)
-1.4 ± 0.4 2.3 ± 3.3 0.9 ± 3.1 -2.1 ± 1.5 -40.3 ± 8.7 -42.4 ± 8.1
B) B-RAFK601E B-RAFD594V
Substructure vdW El Total vdW El Total
A-loopa -117.7 ± 5.8 -261.5 ± 26.4 -379.2 ± 26.6 -105.6 ± 5.3 -108.8 ± 12.2 -214.4 ± 12.8
A-loop-αC-helixb -34.2 ± 2.9 -9.2 ± 12.2 -43.4 ± 12.2 -32.7 ± 2.7 -27.7 ± 7.9 -60.4 ± 7.6
A-loop-P-loopc -16.2 ± 1.8 -18.4 ± 3.8 -34.6 ± 4.4 -20.0 ± 1.7 -1.9 ± 2.4 -21.9 ± 2.9
A-loop-β6-strandd -17.9 ± 2.2 -26.9 ± 7.1 -44.8 ± 7.2 -18.5 ± 2.4 -35.1 ± 7.7 -53.6 ± 7.0
A-loop-F-loope -2.6 ± 0.7 -0.2 ± 1.6 -2.8 ± 1.8 -13.9 ± 2.6 1.1 ± 3.7 -12.8 ± 5.0
A-loop-αG-helixf -2.3 ± 1.2 -56.5 ± 8.3 -58.8 ± 8.4 -0.07 ± 0.1 0.12 ± 1.7 0.05 ± 1.7
Lys601g -12.1 ± 2.6 -141.6 ± 7.2 -153.7 ± 6.8 -20.3 ± 2.2 -102.9 ± 12.8 -123.2 ± 12.7
Lys601-αC-helixh -5.6 ± 1.4 -10.8 ± 4.5 -16.4 ± 4.1 -5.8 ± 0.8 -29.6 ± 3.0 -35.4 ± 2.9
Lys483-Asp594i -0.4 ± 0.6 -52.8 ± 7.7 -53.2 ± 7.5 -0.02 ± 0.0 1.06 ± 0.3 1.04 ± 0.3
Lys601-Asp594j -0.3 ± 0.1 36.4 ± 3.4 36.1 ± 3.3 -0.8 ± 0.7 -6.6 ± 1.9 -7.4 ± 1.7
(K601-D594)-k
(E501-K483)
-2.0 ± 1.4 -48.9 ± 5.7 -50.9 ± 5.5 -4.0 ± 0.6 -9.1 ± 2.1 -13.1 ± 2.0
(K601-D594)-l
(D576-N581)
-2.9 ± 0.5 60.9 ± 4.2 58.0 ± 4.0 -2.6 ± 1.5 -79.0 ± 6.8 -81.6 ± 6.7
aThe interactions between the A-loop (residues 593–623) and the remaining protein. b, c, d, e, fThe interactions between the A-loop and the αC-helix 
(residues 492–506), the P-loop (residues 462–471), the β6 strand (residues 571–578), the F-loop (residues 625–634) and the αG-helix (residues 
660–672), respectively. g, h The interactions between Lys601 and the remaining protein, and Lys601 and the αC-helix, respectively. i The interactions 
between Lys483 and Asp594. jThe interactions between Asp594 and Lys601.k, l The interactions between the Asp594-Lys601 and Lys483-Glu501 
ion pairs and the Asp594-Lys601 and Asp576-Asn581 pairs, respectively.
The van der Waals and the electrostatic contributions to the total interactions energies averaged for the period 10–15 ns of simulation time, along 
with the measured standard deviations, are listed.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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tein sub-structures were calculated, but energy deviations
to due to solvation of the different protein sub-structures
were not calculated specifically. However, the MD simula-
tions were performed in the presence of water, and thus
we consider the resulting protein structures to be gov-
erned by all relevant interaction within the systems stud-
ied, including hydrophobic and other solvation effects,
and electrostatic, van der Waals and intra-molecular
forces. It was seen that forming and breaking of H-bonds
led to very significant structural changes, and such interac-
tions are reasonably well described by the electrostatic
and the van der Waals interactions. These energy terms
were thus considered to provide sufficient information for
this analysis. The effects due to other interactions like the
hydrophobic ones could thus only be discussed in quali-
tatively terms
Molecular dynamics of B-RAFWT
Figures 2A and 2B show the B-RAFWT conformation and
the position of the major catalytic residues after 15 ns of
MD simulation. A two part inter-linked water-mediated
hydrogen bond network (HBN) was identified and
remained stable during the simulation time. The first
HBN was formed between Lys483, Glu501, Asp594,
Gly596, Lys601, Ser607 and water molecules (HBN1).
Asp594 and Lys601 were also joined in a second water-
mediated hydrogen bond bridge with Lys578, Asn581,
Asp576 and Thr599 (HBN2). Thus a unique and inter-
linked HBN situated in the space between the αC-helix, β3
strand, A-loop and β6 strand, was identified. These results
thus confirm the previous results from a 10 ns MD simu-
lation, where a similar HBN was identified [11].
There are five protein elements that interact with the A-
loop. These are the F-loop, P-loop, αG-helix, αC-helix and
β6 strand, with both the P-loop and the αC-helix in close
contact with the A-loop residues that participate in the
above mentioned HBN. The total interactions between
the A-loop and the αC-helix constituted 17% of total A-
loop-protein interactions, whereas the P-loop-A-loop
interactions contributed with 10% (see Table 1A).
The H-bond between Glu501 and Lys601 was observed
during 94% of the simulation time with an average dis-
tance of 2.91 Å ± 0.38. The average distances of Lys483-
Asp594 and Lys601-Asp594 were 3.92 Å ± 0.87 and 3.43
Å ± 0.80, respectively. Direct hydrogen bond between
these residue pairs were observed during 75% and 65% of
the simulation time, respectively. Thus according to the
simulation results, Lys601 and the three catalytic residues,
Lys483, Glu501 and Asp594, interact strongly via tight net
of hydrogen bonds.
The closer distance between Lys483 and Asp594 com-
pared with those seen in the crystal structures (6.02 Å [4])
is due to the lysine conformational change and an orien-
tation toward Asp594. Thus, it appears that the interac-
tions between these catalytic residues in the unbounded
B-RAFWT are stronger than the corresponding interactions
in the bound states, where the inhibitors most likely affect
their conformation [4,9,11,12].
The average electrostatic interaction energy between
Lys483 and Asp594 was -69.0 ± 9.5 kcal/mol, which is
35% of the total A-loop-protein electrostatic interactions
(see Table 1A). The corresponding value for the Lys601-
Glu501 ion pair was -93.8 ± 3.5 kcal/mol, which equals to
47% of the electrostatic A-loop-protein interactions.
Moreover, the Lys601-Glu501 ion pair contributes with
31% of the total A-loop-protein interaction energy (van
der Waals plus electrostatic). The average electrostatic
interaction energy between the Lys601-Asp594 and the
Lys483-Glu501 ion pairs was -70.8 ± 7.5 kcal/mol. The
above results reveal strong interactions between the αC-
helix residue Glu501 and the A-loop residues Asp594 and
Lys601, and thus it is fair to suggest that the interactions
between these two protein substructures presumably have
significant effect on the conformational stability of B-
RAFWT. The strong interactions between Lys601 and the
known catalytic and ATP coordinating residues Asp594,
Glu501 and Lys483 observed previously [11] was thus
seen to be maintained throughout the 15 ns MD simula-
tion. The results indicate that Lys601 has an important
role in the B-RAFWT function and stability, a finding which
is further supported by the experimentally observed
strong kinase activation in the presence of the K601E
mutation. According to these results, one can speculate
that Lys601 plays an important role in the inactive B-
RAFWT phosphorylation, because it interacts strongly with
the ATP coordinating residues and could possibly act as a
regulator of these processes. Moreover, the interaction
between Asp594 and Lys601 was detected in the crystal
structure of the V600E mutant, indicating that our results
were not affected by the loop modelling of a part of the A-
loop [4].
The Lys601 and Glu501 residues were previously identi-
fied to be of key importance to the protein-ligand interac-
tions of B-RAFWT and B-RAFV600E in complexes with a
series of inhibitors. This study was based on a detailed
analysis of MD simulation results, as well as statistical
analysis showing good correlation between the biological
activity and key energy contributions, thus also providing
experimental bases for our hypothesis [11].
We observed that the P-loop residues Phe468 and Val471
were in the closest contact with the DFG motif of the acti-
vation segment, but did also interact with Lys601 and
Leu597, respectively. The Phe468 P-loop residue was ori-
entated towards the αC-helix, not the A-loop, in agree-
ment with recently obtained crystal structures [9]. The
average distance between the Cα atom of Phe468 and theBMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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Cα atom of Val600 was 7.7 Å. The calculated average total
interaction energy between Phe468 and Val600 was only
-0.64 ± 0.1 kcal/mol. However, as both these residues con-
tain non-polar side chains, they could affect the confor-
mational stability of the A-loop through hydrophobic
interactions as has previously been suggested [4].
The overall results from this analysis indicate that the con-
formational stability of the A-loop in B-RAFWT can mainly
be explained by the strong electrostatic interactions
between the residues joined in the HBN and in particular
those between residues in the A-loop and the αC-helix.
Molecular dynamics of B-RAFV600E
The most frequent and one of the strongest activating B-
RAF mutations in melanoma is the substitution Val for
Glu at position 600. Thus Val, that has a small non-polar
side chain, is replaced with an amino acid with larger and
a negatively charged polar side chain. Figures 3A and 3B
show the B-RAFV600E protein conformation after 15 ns of
MD simulation and a close view of the identified HBN
site, respectively. During the simulation time significant
changes were observed in the activation segment folding
and in the position of other protein fragments compared
with the B-RAFWT (see Figures 2A and 3A). The A-loop
adopted an open conformation and moved toward the
space between αC-helix and β6-strand, indicating that the
kinase underwent transition to the active form. The dis-
tance between the OG atom of Ser602 in the A-loop and
the CD2 atom of Leu505 in the αC-helix decreased from
9.4 Å to 4.6 Å, indicating that the activation segment occu-
pied the inhibitors binding site [4,9,11,12]. It should be
mentioned, that the initial conformations for the MD
simulations were taken from the co-crystallized protein-
ligand complexes for both the B-RAF forms, and thus
structural changes were expected during the first part of
the simulations of the unbounded proteins.
The HBN observed in B-RAFWT  underwent significant
changes in B-RAFV600E (see Figures 2B and 3B). The water
mediated hydrogen bond network HBN2, comprised of
Asn581, Asp576, Asp594, Thr599 and Lys601, was disor-
dered compared to the corresponding HBN2 in the wild
type. The HBN1 portion, including the Lys483, Glu501
and Ser602, was not linked to HBN2 due to the disruption
of the Lys483-Asp594 and Glu501-Lys601 ion pair's links.
The average electrostatic interaction energy between
Lys483 and Asp594 was almost two times less negative
than in the wild type. Thus one of the important factors
for stabilizing the A-loop conformation according to the
results in the previous paragraph was not present in the B-
RAFV600E mutant.
Previously, a detailed analysis was performed of the struc-
tural changes within the HBN caused by the Val for Glu
substitution at position 600 on the basis of a 10 ns simu-
lation [11]. According to our hypothesis, the electrostatic
interaction energy between Asp594-Lys601 and Asn581-
Asp576 ion pairs becomes less negative at 4.5 ns due to
conformational change of Lys601, which contributes to
the Glu600 conformational change at 4.8 ns, causing the
Glu600-αC-helix interaction energy to become less nega-
tive as well (see Figure Eight in [11]). Thus by analysing
the evolution in the electrostatic energies of key substruc-
tures, we were able to identify some of the underlying
processes that contribute to the overall destabilization of
the A-loop conformation.
In order to strengthen the scientific basis for our hypoth-
esis and obtain a more precise description, we made a
similar study based on the 15 ns MD simulation presented
in this paper. Thus curves for the electrostatic interaction
energies corresponding to those previously published
were made (not shown here). It was confirmed that the
systems had already reached to an equilibrium in the 10
ns simulation, and maintained this equilibrium in the
10–15 ns interval, i.e. all the curves had a constant value
in this interval.
The comparison with the B-RAFWT results shows that the
conformation of Lys601 and the layout of the HBN were
affected by the Val to Glu600 residue replacement. The
total interaction energy between the Asp594-Lys601 and
Lys483-Glu501 ion pairs was 67.9 kcal/mol less negative
than in B-RAFWT due to the disruption of the H-bonds that
linked these two ion pairs in the wild type B-RAF (see
Table 1A). Thus our results indicate that the V600E substi-
tution leads to more unfavourable A-loop-αC-helix inter-
actions compared to the wild type, which can cause
displacement of the A-loop. Conversely, these interac-
tions were highly favourable in the wild type, stabilizing
the A-loop kinase conformation (see Table 1A). The effect
of the modelled portion of the A-loop was discussed pre-
viously, and based on the analysis of the electrostatic
energy mentioned above, it was argued that the conforma-
tional changes of key residues like Glu600 and Lys601
were not significantly affected by this model [11].
Our results also showed that the A-loop-P-loop interac-
tions were stable through the simulation and had similar
total interaction energies in both the B-RAFWT and B-
RAFV600E (see Table 1A and Figure 4A, as well as Figure
Eight C in [11]). This indicated that the P-loop is unlikely
to have a major contribution to the destabilization of the
HBN in B-RAFV600E.
These results quantitatively demonstrate that the repulsive
A-loop-αC-helix interactions and the interactions
between the other participants in the HBN are likely to
significantly affect the mechanism of the B-
RAFV600Eactivation. The repulsive electrostatic forces
between the A-loop, the αC-helix and the P-loop wereBMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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B-RAFV600E Figure 3
B-RAFV600E. A) The conformation of B-RAFV600E after 15 ns of simulation time. The part of the A-loop resolved in the crystal 
structure (A-loop1) and the modelled portion (A-loop2) are shown. B) A close look at the conformation of the major catalytic 
residues and the identified hydrogen bond network in the unbounded B-RAFV600E after 15 ns of simulation time. The dotted 
lines and the adjacent values represent the H-bonds and their distances.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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Electrostatic energy interactions in B-RAFWT, B-RAFD594V and B-RAFK601E Figure 4
Electrostatic energy interactions in B-RAFWT, B-RAFD594V and B-RAFK601E. A) The total electrostatic interaction 
energies between the A-loop and the P-loop in B-RAFWT, B-RAFD594V and B-RAFK601E. B) The electrostatic interaction energy 
between the A-loop and the αC-helix, and the A-loop-1 (residues 593–602, the A-loop portion solved in the crystal struc-
tures) and the αC-helix in B-RAFK601E. C) The electrostatic interaction energy between the A-loop and the αC-helix, and the 
A-loop-1 and the αC-helix in B-RAFD594V.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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identified as the main mechanism of B-RAF kinase activa-
tion in a previous MD study of the V600E and V599Ins
mutants, but the specific contributions of the αC-helix
and the P-loop were not specified [10].
The data above indicate the important role of the electro-
static interactions between the participants in the HBN in
provoking different conformational changes in the differ-
ent kinase types.
Molecular dynamics of B-RAFK601E
The strong kinase activation in the presence of K601E
mutations is difficult to explain in the frame of the previ-
ously published structural model in which mainly the
interactions between the A-loop and the P-loops were
considered to be of a key importance [4]. According to the
B-RAFWT MD results above and available crystal structures,
the Lys601 is placed in front of and interacts strongly with
the catalytic Asp594 residue. Our MD data for the wild
type protein showed that this residue also interacts with
the ATP coordinating residues Glu501 and Lys483. Thus,
it is reasonable to suggest that mutation and subsequent
conformational changes at this protein site would also
promote significant changes in kinase activity. As Lys, an
amino acid with a positively charged side chain, it is
replaced with Glu that has a negatively charged side chain,
the observed HBN is likely to be affected by this mutation.
Figures 5A and 5B show the B-RAFK601E protein conforma-
tion after 15 ns of MD simulation and a close view of the
identified HBN site, respectively. The HBN observed in B-
RAFWT underwent significant changes compared to the
wild type B-RAF, particularly due to disordering of the
HBN1 portion that is comprised of Lys483, Glu501,
Asp594, Glu601 and water molecules. In addition to
forming H-bonds with Glu501 and Asp594, Lys483 is also
hydrogen bonded to Glu601. All these H-bonds were sta-
ble during the whole simulation time, provoking confor-
mational changes in HBN1 (see Figure 5B). It is notable
that the Lys483-Asp594 had an average distance of 3.32 Å
± 0.96 and an H-bond was observed during 80% of the
simulation time. However, the electrostatic interaction
energy between these residues was less negative than in B-
RAFWT and at the same time more negative than in B-
RAFV600E (see Tables 1A and 1B). Thus, the Lys483-Asp594
link, identified as an important factor for the B-RAFWT A-
loop conformational stability in the analysis above, was
shown to be weakened as a result of the Lys to Glu replace-
ment at position 601, although to a lesser degree than for
the V600E mutant.
The unfavourable interactions were mainly seen to be due
to the Glu601-αC-helix repulsive interactions, in particu-
lar those between the Glu501 and the Glu601 residues.
The Glu601-αC-helix electrostatic interaction energy was
thus 62.5 kcal/mol less negative than the corresponding
value for the Lys601-αC-helix interaction in B-RAFWT and
12.0 kcal/mol less negative than in B-RAFV600E. The aver-
age electrostatic interaction energy between the Lys483-
Glu501 and the Asp594-Glu601 ion pair's was 21.9 kcal/
mol less negative than for the corresponding interaction
in the wild type B-RAF. The Asp594-Glu601 electrostatic
interaction had a positive value due to the repulsive forces
between these two negatively charged residues, opposite
to the corresponding strong attractive forces between
Asp594 and Lys601 in both B-RAFWT and B-RAFV600E (see
Tables 1A and 1B).
Similarly to the V600E mutant, our results indicate that
the disordering of the HBN and the reduction of the elec-
trostatic interaction energy between the A-loop and the
αC-helix compared to the wild type is an important factor
for B-RAFK601E activation. Presumably, the introduction of
stronger repulsive forces between these two protein sub-
structures by this mutation, is one of the major factors
contributing to the change of the A-loop to its active form.
On the other hand, as the corresponding A-loop – P-loop
energy was seen not to be affected by this mutation (see
Table 1B), but P-loop residues might affect the A-loop
conformation through hydrophobic interactions as previ-
ously discussed.
According to our results, the significant energy contribu-
tion came mostly from the residues in the A-loop-1 por-
tion and the αC-helix (see Figure 4B), whereas the higher
energy fluctuations were provoked by the modelled A-
loop-2 portion. The average electrostatic energy between
the A-loop and the αC-helix and the corresponding energy
for A-loop1 reached a reasonable equilibrium after 2 ns of
simulation time. As a result, the average electrostatic inter-
actions energy between the A-loop and the αC-helix was -
9.2 ± 12.2 kcal/mol, i.e. about 3–4 times less negative
than in the wild type kinase (see Table 1B).
Considering the data from the MD simulation of B-
RAFV600Ins mutant [10] that indicated the same activation
mode, we suggest that this mechanism of B-RAF activation
by displacement of the A-loop is common in the most of
the activating mutants. For instance, the mutation of
Gly596 to larger and charged residues, as for example
Arg596, would be expected to provoke a similar disrup-
tion of the electrostatic interactions between the A-loop
and the αC-helix. These data demonstrate quantitatively
that the changes in the HBN and the reorganisation of the
catalytic and ATP coordinating residues joined in the HBN
can contribute to the explanation of changes in the kinase
activity and conformational stability.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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B-RAFK601E Figure 5
B-RAFK601E. A) The conformation of B-RAFK601E after 15 ns of simulation B) A close look at the conformation of the major 
catalytic residues and the identified hydrogen bond network in the unbounded B-RAFK601E after 15 ns of simulation time. The 
dotted lines and the adjacent values represent the H-bonds and their distances.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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Molecular dynamics of B-RAFD594V
The Asp to Val substitution at position 594 eliminates the
kinase activity, which would be expected due to the cata-
lytic functions of aspartic acid in that position seen in
many other kinases. Asp which has a negatively charged
polar side chain is thus replaced with Val that has a non-
polar side chain. Figures 6A and 6B show the B-RAFD594V
protein conformation after 15 ns of MD simulation and a
close view of the identified HBN site, respectively. The
most significant structural changes compared with B-
RAFWT were seen in the A-loop, the αE-helix and the F-
loop. Similarly to the other mutants the HBN in B-
RAFD594V was disordered due to the D594V mutation. This
substitution did lead to a change in the Phe595 conforma-
tion which adopted position that occupied the ATP bind-
ing site in a similar way as the inhibitors [4,9,11,12],
restricting the flexibility of the A-loop.
The overall electrostatic interactions between the αC-helix
and the A-loop were similar to the corresponding interac-
tions in the wild type and much stronger than for the
active mutants, B-RAFV600E and B-RAFK601E, (see Figure 4C
and Tables 1A–B). While the H-bonds involving Asp594
were disrupted due to this mutation, a strong average elec-
trostatic interaction emerged between the Val594-Lys601
and the Asp576-Asn581 ion pair's. The Asp576 is within
the β6-strand, indicating the A-loop – β6-strand interac-
tions also contribute to the stability of this impaired activ-
ity mutant.
In the B-RAFD594V mutant, as in the other studied kinases
types, the portion of the A-loop solved in the crystal struc-
tures played a major role for the stability of these interac-
tions. After 3 ns of simulation time the αC-helix-A-loop-1
electrostatic interactions reached a reasonable equilib-
rium at about -30 kcal/mol (see Figure 4C). The A-loop-2
portion had insignificant energy contribution with small
fluctuations in the range of -5 to + 5 kcal/mol.
Our results indicate that this mutation thus stabilized the
A-loop conformation and resulted in an auto-inhibition
mechanism, most likely by occupying the ATP binding
site by Phe595.
Proposal for a molecular basis of the B-RAF activation
Based on the MD results above and all available crystal
structures we propose a structural basis that could explain
the experimentally observed B-RAF deviations in the
kinase activity induced by several mutations. According to
our hypothesis, the electrostatic interactions between the
participants in the identified HBN in B-RAFWT presumably
play a major role in the kinase activity variations. Most of
the residues joined in this network are either fractions of
the A-loop or they are well known catalytic residues. Thus,
the direct or indirect disordering of the HBN can lead to
large kinase activity deviations and to conformational
changes in the A-loop. Some mutations destabilize the
HBN in such a way that it presumably promotes the
kinase to change to its active form, while other mutations
stabilize the A-loops conformation, causing the kinase to
remain inactive.
It should be mentioned that very substantial structural
changes provoked by the different mutations were
observed in this work. Although some errors might be
introduced through the MD simulation, the general
trends seen in these simulations are very clear, and thus
we consider our conclusions to be trustworthy.
The mutation of the residues that are joined in the identi-
fied B-RAFWT HBN or are placed in neighbouring posi-
tions, are considered to directly disorder the HBN and as
a consequence to affect the activation segments conforma-
tion. It has been established that Lys483 and Asp594 are
highly conserved residues and of key importance for the
ATP binding and coordination in the kinase family. More-
over, the Lys483-Glu501 ion pair interactions increase the
phosphorylation potential [24,25]. According to our MD
results, the substitution of Lys601 destabilized the interac-
tions in the HBN, particularly affecting the interactions
between the A-loop and the αC-helix and promoting sig-
nificant conformational changes in the A-loop. Con-
versely, the Asp594 mutation rearranged the interactions
in the HBN in such a way that strong A-loop – αC-helix
interactions were maintained. The experimental results
showed that B-RAFK483M  and B-RAFD594V  are the only
known mutants with a lack of kinase activity, whereas the
B-RAFK601E is one of the four mutation positions that
cause the strongest activation [4]. B-RAFV600E is one of the
most strongly activating [4] mutants. Based on our MD
data for the V600E mutation demonstrated that Val for
Glu substitution at position 600 (neighbour to the HBN
participant Lys601) we observed both disordering of the
HBN and increased repulsive electrostatic interactions
between the A-loop and the αC-helix. Thus by replacing
Val with a larger and more charged residue like Glu,
increased repulsive forces between key residues were
introduced, which according to our observations leads to
breaking of the H-bonds between the αC-helix residue
Glu501 and the A-loop residues Asp594 and Lys601. At
the same time the activation segment is seen to move to a
more open conformation, and it is our hypothesis that it
moves to its active form. Other substitution of Val600 to
large and charged residues, such as V600D, V600K and
V600R, will most likely have similar impact on the Lys601
conformation and are therefore also expected to disorder
the HBN and activate the B-RAF.
Several other residues with known mutations that affect
the kinase activity are joined in the identified HBN or areBMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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B-RAFD594V Figure 6
B-RAFD594V. A) The conformation of B-RAFD594V after 15 ns of simulation time. B) A close look at the conformation of the 
major catalytic residues and the identified hydrogen bond network in the unbounded B-RAFD594V after 15 ns of simulation time. 
The dotted lines and the adjacent values represent the H-bonds and their distances.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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placed at neighbouring positions and can thus directly
destabilize the HBN and affect the A-loops position. It has
been shown that the mutations of the Asn581, Thr599,
Phe595 and Leu597 residues lead to significant increase
in the kinase activity [4], whereas G596R mutant causes
reduced activity compared to the B-RAFWT basal activity
(see Table S 1 in the supporting information of Ref [4]).
The Asn581 is a part of HBN2 by forming water mediated
H-bond with Asp594 and a strong H-bond with the back-
bone nitrogen of Phe595 (see Figure 2A). Likewise,
Thr599 forms a H-bond with Asp576 (average distance of
3.02 Å ± 0.39) which remained stable during 83% of the
simulation time (see Figure 2A), thus the T599I mutation
should induce changes in the HBN. Moreover, the phos-
phorylation of Thr599 will most probably destabilize the
HBN and affect the conformation of the A-loop, which
can explain why this process is needed for B-RAFWT activa-
tion [5]. The substitution of the Phe595 residue (adjacent
to the HBN participant Asp594) could potentially destabi-
lize the HBN by flipping the conformation of aspartic
acid. We observed that Leu597 makes a close contact and
has strong van der Waals interactions with Lys483 (see
Figure 7). Thus, the substitution of Leu597 (L597R) can
presumably destabilize the interaction with Lys483 and
consequently disrupt the HBN. Indeed such mutation will
also disturb the hydrophobic interactions with the P-loop,
as has been proposed previously [4]. It is reasonable to
expect that the substitution of residues that disorder the
HBN can affect the A-loop conformation. Further, the
Some of the residues participating in indirect disordering of the HBN in B-RAFWT Figure 7
Some of the residues participating in indirect disordering of the HBN in B-RAFWT. A close look at the conforma-
tion of the major catalytic residues, the DFG motif and the P-loop residues participating in the disordering of the identified 
hydrogen bond network in the unbounded B-RAFWT after 15 ns of simulation time. The dotted lines and the adjacent values 
present the H-bonds and their distances.BMC Structural Biology 2009, 9:47 http://www.biomedcentral.com/1472-6807/9/47
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deactivating mutation of Gly596 (G596R) that is involved
in the HBN1 portion of the network could form stable
hydrogen bond with the catalytic Asp594 residue and
water mediated H-bond with the ATP coordinating
Lys483 residue (see Figure 7) and provoke rearrangements
of the HBN.
The data from the MD simulations in a combination with
the experimental results support our hypothesis and sug-
gest that the mutations of residues in the identified HBN
and in particular those which are in close contact with the
catalytic residues are of a key importance for the kinase
activity. It should be noted that mutations of residues like
Val600, Lys601, Phe595, Gly596 and Leu597, which
interact directly with the catalytic and ATP coordinating
residues Lys483 and Asp594, promote stronger increase in
kinase activity than residues like Thr599 and Asn581,
which are a part of the HBN, but do not interact directly
with the catalytic residues. (See Table S Four in the sup-
porting information of ref [4]). This observation suggests
an additional support and a logical explanation of the
proposed model for explaining the experimentally
observed activities of the mutants.
Mutations of residues that interact with the residues
involved in the HBN can indirectly destabilise the HBN
and consequently cause activity deviations. One of the
strongly activating B-RAF mutations is G467A. As it has
been previously suggested, this mutation could destabi-
lize the interactions between the P-loop and the DFG
motif due to the close contact with Leu597 seen in the
crystal structures with the inhibitor Sorafenib [4]. How-
ever, our MD results suggest that Leu597 also makes a
close contact with Lys483 and Gly467 and interacts with
Met482 as well (see Figure 7). Thus, the mutation of the
Gly467 could have indirect impact on the HBN. Several
other mutations in the P-loop may affect the HBN stabil-
ity in an indirect way and consequently affect the A-loop
conformation too. Hence we propose a multiple mecha-
nism of the B-RAF activation and conformational stabil-
ity.
Conclusion
A novel molecular basis of B-RAF activation was suggested
that could explain the experimentally observed deviations
in the kinase activity induced by several mutations.
According to our analysis, the mutations which directly or
indirectly destabilized the interactions between the resi-
dues within the identified hydrogen bond network in B-
RAFWT contribute to changes in the electrostatic interac-
tions between the A-loop and the αC-helix. This mecha-
nism presumably plays a major role in the B-RAF
activation by promoting the activation segment to flip
into an active form in the activating mutants. Conversely,
in the mutants with an impaired kinase activity, such as B-
RAFD594V, and in B-RAFWT, the A-loop and the αC-helix
interactions stabilized the kinase inactive form according
to our analysis. By analysing interactions and conforma-
tional changes involving the main known catalytic resi-
dues within B-RAF we have indentified significant
structural changes that can to reasonable extent explain
activity deviations caused by several mutations.
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